IL213093A0 - Crystalline forms of a 3-carboxypropyl-aminotetralin compund - Google Patents

Crystalline forms of a 3-carboxypropyl-aminotetralin compund

Info

Publication number
IL213093A0
IL213093A0 IL213093A IL21309311A IL213093A0 IL 213093 A0 IL213093 A0 IL 213093A0 IL 213093 A IL213093 A IL 213093A IL 21309311 A IL21309311 A IL 21309311A IL 213093 A0 IL213093 A0 IL 213093A0
Authority
IL
Israel
Prior art keywords
aminotetralin
compund
carboxypropyl
crystalline forms
crystalline
Prior art date
Application number
IL213093A
Other languages
English (en)
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of IL213093A0 publication Critical patent/IL213093A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/22Separation; Purification; Stabilisation; Use of additives
    • C07C231/24Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL213093A 2008-12-10 2011-05-24 Crystalline forms of a 3-carboxypropyl-aminotetralin compund IL213093A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12125408P 2008-12-10 2008-12-10
PCT/US2009/067271 WO2010068649A1 (en) 2008-12-10 2009-12-09 Crystalline forms of a 3-carboxypropyl-aminotetralin compound

Publications (1)

Publication Number Publication Date
IL213093A0 true IL213093A0 (en) 2011-07-31

Family

ID=42122774

Family Applications (1)

Application Number Title Priority Date Filing Date
IL213093A IL213093A0 (en) 2008-12-10 2011-05-24 Crystalline forms of a 3-carboxypropyl-aminotetralin compund

Country Status (21)

Country Link
US (4) US8101794B2 (https=)
EP (1) EP2376427B1 (https=)
JP (1) JP5650657B2 (https=)
KR (1) KR101685187B1 (https=)
CN (1) CN102245564B (https=)
AR (1) AR074592A1 (https=)
AU (1) AU2009324709B2 (https=)
BR (1) BRPI0922920A2 (https=)
CA (1) CA2745441C (https=)
CL (1) CL2011001391A1 (https=)
CO (1) CO6390054A2 (https=)
ES (1) ES2645087T3 (https=)
IL (1) IL213093A0 (https=)
MX (1) MX2011006209A (https=)
MY (1) MY179041A (https=)
NZ (1) NZ593377A (https=)
RU (1) RU2512390C2 (https=)
SG (1) SG172016A1 (https=)
TW (1) TWI449685B (https=)
WO (1) WO2010068649A1 (https=)
ZA (1) ZA201104319B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2482107C2 (ru) 2007-12-11 2013-05-20 Тереванс, Инк. Производные 3-карбоксипропил-аминотетралина и родственные соединения в качестве антагонистов mu-опиоидного рецептора
WO2009076399A2 (en) 2007-12-11 2009-06-18 Theravance, Inc. Aminotetralin compounds as mu opioid receptor antagonists
AU2010295464B2 (en) * 2009-09-18 2015-11-26 Merck Sharp & Dohme Corp. Use of opioid receptor antagonist for gastrointestinal tract disorders
US8658691B2 (en) * 2011-09-30 2014-02-25 Theravance, Inc. Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844368B1 (en) * 1998-12-22 2005-01-18 Edward Roberts Compounds useful in pain management
US6498196B1 (en) * 1998-12-22 2002-12-24 Edward Roberts Compounds useful in pain management
US6231594B1 (en) 1999-08-11 2001-05-15 Radiant Medical, Inc. Method of controlling body temperature while reducing shivering
WO2003097586A1 (en) * 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Aminotetralin-derived urea modulators of vanilloid vr1 receptor
RU2005134364A (ru) * 2003-04-08 2006-06-10 Проджиникс Фармасьютикалз, Инк. (Us) Комбинированное лечение запора
SE0301794D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use III
JP2010509227A (ja) 2006-11-07 2010-03-25 ネクター セラピューティックス エイエル,コーポレイション オピオイド作動薬およびオピオイド拮抗薬の用量形態および同時投与
EP1997493A1 (en) * 2007-05-28 2008-12-03 Laboratorios del Dr. Esteve S.A. Combination of a 5-HT7 receptor ligand and an opioid receptor ligand
RU2482107C2 (ru) * 2007-12-11 2013-05-20 Тереванс, Инк. Производные 3-карбоксипропил-аминотетралина и родственные соединения в качестве антагонистов mu-опиоидного рецептора
WO2009076399A2 (en) 2007-12-11 2009-06-18 Theravance, Inc. Aminotetralin compounds as mu opioid receptor antagonists
US8153686B2 (en) 2008-04-01 2012-04-10 Theravance, Inc. Amino- and amido-aminotetralin derivatives and related compounds as mu opioid receptor antagonists

Also Published As

Publication number Publication date
TWI449685B (zh) 2014-08-21
KR20110093938A (ko) 2011-08-18
AU2009324709A1 (en) 2011-06-30
BRPI0922920A2 (pt) 2019-09-24
MY179041A (en) 2020-10-26
SG172016A1 (en) 2011-07-28
CO6390054A2 (es) 2012-02-29
RU2011128393A (ru) 2013-01-20
KR101685187B1 (ko) 2016-12-09
AR074592A1 (es) 2011-01-26
EP2376427A1 (en) 2011-10-19
US8324236B2 (en) 2012-12-04
CL2011001391A1 (es) 2011-11-11
US8486958B2 (en) 2013-07-16
WO2010068649A1 (en) 2010-06-17
US8101794B2 (en) 2012-01-24
US20130345466A1 (en) 2013-12-26
CA2745441C (en) 2017-10-17
US20120088834A1 (en) 2012-04-12
CA2745441A1 (en) 2010-06-17
EP2376427B1 (en) 2017-08-02
CN102245564A (zh) 2011-11-16
MX2011006209A (es) 2011-07-12
JP5650657B2 (ja) 2015-01-07
JP2012511580A (ja) 2012-05-24
RU2512390C2 (ru) 2014-04-10
CN102245564B (zh) 2015-04-01
US20130065916A1 (en) 2013-03-14
US8969367B2 (en) 2015-03-03
TW201026646A (en) 2010-07-16
AU2009324709B2 (en) 2015-07-16
ES2645087T3 (es) 2017-12-04
US20100144881A1 (en) 2010-06-10
ZA201104319B (en) 2012-03-28
NZ593377A (en) 2013-07-26

Similar Documents

Publication Publication Date Title
LT2155200T (lt) Karbamoil-cikloheksano darinio kristalinė forma
TWI372530B (en) Configuration of a repeater
GB0819182D0 (en) Crystalline forms
IL214126A0 (en) Crystalline insulin-conjugates
ZA201008019B (en) A crystalline form of posaconazole
AU320778S (en) A watch
EP2339918A4 (en) PREPARATION OF A QUINOLINYLOXYDIPHENYLCYCLOPROPANEDICARBOXAMIDE
GB0908293D0 (en) Herbicidal compounds
GB0808840D0 (en) A compound structure
ZA201105045B (en) Crystalline forms of genistein
ZA201100999B (en) Synthesis of a crystalline silicoaluminophosphate
SI2358676T1 (sl) Kristalinična oblika 4-(2-(2-fluorofenoksimetil)fenil)piperidinske spojine
GB0917934D0 (en) Herbicidal compounds
GB0722927D0 (en) A watch
GB0910536D0 (en) A compliant element
IL210777A0 (en) Crystalline forms of a pyridine derivative
GB0916442D0 (en) A sleeping aid
IL213093A0 (en) Crystalline forms of a 3-carboxypropyl-aminotetralin compund
IL214028A0 (en) A novel cyanopyrimidine derivative
GB0813347D0 (en) A set of parts
IL200048A (en) Solid forms of microbiocide
PT2173710E (pt) Nova forma cristalina
GB0916267D0 (en) Herbicidal compounds
IL195092A0 (en) Crystalline form of (s)-1-phenylethylammonium (r)-diphenyl-methanesulphinyl-acetate
IL206021A0 (en) Crystalline form of azelastine

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed